| PERIOD ENDING | 3-Jul-09 | 3-Apr-09 | 9-Feb-09 | 2-Jan-09 | | Total Revenue | 3,898,000 | 4,111,700 | 3,952,400 | 3,952,400 | | Cost of Revenue | 3,156,000 | 3,169,300 | 3,083,400 | 3,083,400 | | | Gross Profit | 742,000 | 942,400 | 869,000 | 869,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 247,000 | 258,800 | 261,200 | 261,200 | | Non Recurring |
-
| 18,900 |
-
|
-
| | Others | 270,000 | 274,000 | 282,200 | 282,200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 225,000 | 390,700 | 325,600 | 325,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15,000 | 8,900 | 3,200 | 3,200 | | Earnings Before Interest And Taxes | 240,000 | 399,600 | 328,800 | 328,800 | | Interest Expense | 55,000 | 69,100 | 68,700 | 68,700 | | Income Before Tax | 185,000 | 330,500 | 260,100 | 260,100 | | Income Tax Expense | 52,000 | (51,800) | 99,500 | 99,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 133,000 | 382,300 | 160,600 | 160,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 133,000 | 382,300 | 160,600 | 160,600 | | Preferred Stock And Other Adjustments | (2,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $131,000 | $382,300 | $160,600 | $160,600 |
|
2.03% Nasdaq 0.00%
Income Statement
